Calculation of Conversion Price. The conversion price (the “Conversion Price”) shall be $0.0015 and shall be subject to adjustment only for splits, reverse splits, Common Stock dividends and similar recapitalizations, but shall not be subject to any other anti-dilution protections, including but not limited to dilution due to financings.
Appears in 3 contracts
Sources: Convertible Note (RespireRx Pharmaceuticals Inc.), Convertible Note (RespireRx Pharmaceuticals Inc.), Convertible Note (RespireRx Pharmaceuticals Inc.)